Fact CheckerSign in

NCT05887986Completed

Management of Dyspnea: Use of Hand Held Fan

Management of Pulmonary Toxicity-related Dyspnea: Effect of Hand-held Fan Airflow Stimulation

Source: ClinicalTrials.gov · Last updated 17 Jun 2024

Brief summary (registry, in English)

This research is planned as a randomized controlled experimental study to determine the effect of air stimulation to the face with a hand fan in the management of dyspnea in lung cancer patients. The universe of the research was carried out between December 2022 and February 2024, Izmir Provincial Health Directorate, University of Health Sciences, Suat Seren Chest Diseases and Surgery Training and Research Hospital will consist of cancer patients. Individuals who meet the sampling selection criteria from the specified universe will constitute the sample of the research. The sample number of the research was determined as a result of the power analysis made with the G\*power program. As a result of the power analysis, based on the t-test in independent groups, the minimum number of samples to be taken was 27 people for a group with 1:1 ratio, 0.80 power, effect value 0.80 and 0.05 significance level. Randomization of the sample will be ensured by accepting the first patient who applied to the outpatient chemotherapy unit randomly and with an appointment at the beginning of the study to the experimental group, and the next patient to the control group. Considering the losses, it is planned to work with 60 people, 30 people in the intervention group and 30 people in the control group. Individual Descriptive Information Form, Medical Research Council Scale (mMRC), Cancer Dyspnea Scale, Vital Signs Follow-up Form, Eastern Cooperative Oncology Group (ECOG) Performance Scale and General Comfort Scale Short Form will be used.

Status (registry)
Completed
Study type
Interventional
Enrollment
56 (actual)
First submitted
18 Apr 2023
Start date
22 Dec 2022
Primary completion date
9 Feb 2024
Lead sponsor
Aysegul Celik
Diseases
Lung cancer
NCT number
NCT05887986

What you commit to

  • Study type: Interventional
  • Participants enrolled: 56
  • From 22 Dec 2022 to the primary completion date, 9 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Having a psychiatric illness

Other

  • Having a fever of 38⁰C and above in the last 24 hours
  • Inability to communicate cognitively and verbally

Who the study is looking for

  • 18 years and older
  • Diagnosed with lung cancer
  • mMRC dyspnea scale score ≥2
  • ECOG Performance Score score ≥3
  • Volunteered to participate in the research

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Izmir Provincial Health Directorate Health Sciences University Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital
Coordinator of this site? Confirm its status
IzmirTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.